Impact of chronic DDD pacing on time-domain indexes of heart rate variability in patients with hypertrophic obstructive cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 12, 1999, Pages 1808-1813

  Simantirakis, E N ^a   Kochiadakis, G E ^a   Kanakaraki, M K ^a   Marketou, M E ^a   Parthenakis, F I ^a   Kanoupakis, E M ^a   Vardas, P E ^a,b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b FESC   (Greece)

Author keywords

DDD pacing; Heart rate variability; Hypertrophic obstructive cardiomyopathy

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEART PACING; HEART RATE VARIABILITY; HEART RHYTHM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG TERM CARE; MALE; TREATMENT OUTCOME; VAGUS TONE;

EID: 0033384801     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00415.x     Document Type: Article

References (22)

1. 1. McDonald K, McWilliams E, O'Keeffe B, et al. Functional assessment of patients treated with permanent dual-chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988; 9:893-898.
2. 2. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339:318-323.
3. 3. Fananapazir L, Cannon RO, Tripodi D, et al. Impact of dual-chamber pacing in patients with hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation 1992; 85:2149-2161.
4. 4. Fananapazir L, Epstein ND, Curiel RV, et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic Improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90:2731-2742.
5. 5. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29:435-441.
6. 6. Kappenberger L, Linde C, Daubert C, et al., and the PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997; 18:1249-1256.
7. 7. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989; 80:1489-1492.
8. 8. Farrell TG, Paul V, Cripps TR, et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 1991; 83:945-952.
9. 9. Bigger JT, Kleiger RE, Fleiss JL, et al., for the Multicenter Postinfarction Research Group. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1988; 61:208-215.
10. 10. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18:687-697.
11. 11. Kleiger RE, Miller JP, Bigger JT, et al., for the Multicenter Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-262.
12. 12. Counihan PJ, Fei L, Bashir Y, et al. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation 1993; 88:1682-1690.
13. 13. Gilligan DM, Chan WL, Sbarouni E, et al. Autonomie function in hypertrophic cardiomyopathy. Br Heart J 1993; 69:525-529.
14. 14. Ajiki K, Murakawa Y, Yanagisawa-Miwa A, et al. Autonomie nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. Am J Cardiol 1993; 71:1316-1320.
15. 15. Fei L, Slade AK, Prasad K, et al. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1995; 26: 472-480.
16. 16. Bonaduce D, Petretta M, Betochi S, et al. Heart rate variability in patients with hypertrophic cardiomyopathy: Association with clinical and echocardiographic features. Am Heart J 1997; 134: 165-172.
17. 17. Limbruno U, Strata G, Zucchi R, et al. Altered autonomie cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J 1998; 19:146-153.
18. 18. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979; 43:1242-1244.
19. 19. Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J1996; 17:354-381.
20. 20. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation.) ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998; 31:1175-1209.
21. 21. Pak PH, Maughan WL, Baughman KL, et al. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart. Similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. Circulation 1998; 98:242-248.
22. 22. Simantirakis EN, Kanoupakis EM, Kochiadakis GE, et al. The effect of DDD pacing on ergospirometric parameters and neurohormonal activity in patients with hypertrophic obstructive cardiomyopathy. PACE 1998; 21(Pt 2):2269-2272.